These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25721124)

  • 1. Lupus nephritis: through the looking-glass.
    Whittier WL; Reiser J
    Lupus; 2015 May; 24(6):533-5. PubMed ID: 25721124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary and secondary glomerular diseases].
    Birck R; Banas B
    Dtsch Med Wochenschr; 2011 Apr; 136(14):703-5. PubMed ID: 21448831
    [No Abstract]   [Full Text] [Related]  

  • 3. Peculiar type of focal and segmental lupus glomerulitis: glomerulonephritis or vasculitis?
    Ferrario F; Napodano P; Giordano A; Gandini E; Boeri R; D'Amico G
    Contrib Nephrol; 1992; 99():86-93. PubMed ID: 1458932
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: a large cohort study from China.
    Qin DD; Song D; Huang J; Yu F; Zhao MH
    Lupus; 2015 May; 24(6):546-57. PubMed ID: 25411257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Con: Biomarkers in glomerular diseases: putting the cart before the wheel?
    De Vriese AS; Fervenza FC
    Nephrol Dial Transplant; 2015 Jun; 30(6):885-90. PubMed ID: 25994657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
    Morel-Maroger L; Adam C; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
    [No Abstract]   [Full Text] [Related]  

  • 7. Lupus nephritis: lessons from the path lab.
    Kashgarian M
    Kidney Int; 1994 Mar; 45(3):928-38. PubMed ID: 8196299
    [No Abstract]   [Full Text] [Related]  

  • 8. Opponent's comments.
    Kretzler M; Mariani LH
    Nephrol Dial Transplant; 2015 Jun; 30(6):891. PubMed ID: 25994658
    [No Abstract]   [Full Text] [Related]  

  • 9. Moderator's view: Biomarkers in glomerular diseases--translated into patient care or lost in translation?
    Ronco P
    Nephrol Dial Transplant; 2015 Jun; 30(6):899-902. PubMed ID: 25994661
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum-soluble urokinase receptor concentration in primary FSGS.
    Maas RJH; Wetzels JFM; Deegens JKJ
    Kidney Int; 2012 May; 81(10):1043-1044. PubMed ID: 22543906
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lupus nephritis in children and adolescents: clinical and morphologic aspects and clinico-morphologic correlations].
    Bogdanović R; Nikolić V; Ognjanović M; Dimitrijević J; Marković-Lipkovski J; Pasić S; Minić A; Stajić N
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():1-5. PubMed ID: 12583306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The present status of focal glomerulonephritis.
    Heptinstall RH
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():287-300. PubMed ID: 4157259
    [No Abstract]   [Full Text] [Related]  

  • 14. Classification of glomerulonephritis based on morphology.
    Churg J; Duffy JL
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():43-61. PubMed ID: 4536435
    [No Abstract]   [Full Text] [Related]  

  • 15. CD80 and suPAR: diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis?
    Davin JC
    Pediatr Nephrol; 2014 Aug; 29(8):1465-6. PubMed ID: 24839215
    [No Abstract]   [Full Text] [Related]  

  • 16. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response.
    Cara-Fuentes G; Johnson RJ; Reiser J; Garin EH
    Pediatr Nephrol; 2014 Aug; 29(8):1467-8. PubMed ID: 24817342
    [No Abstract]   [Full Text] [Related]  

  • 17. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
    Kim YG; Kim HW; Cho YM; Oh JS; Nah SS; Lee CK; Yoo B
    Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus nephritis in an anti-nuclear antibody-negative young male. The simultaneous presence of class III and class V renal lesions.
    Khajehdehi P; Islam SF; Salinas-Madrigal L; Bastani B
    Clin Nephrol; 1999 Jun; 51(6):379-82. PubMed ID: 10404699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of glomerulonephritis based on morphology.
    Habib R
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():17-41. PubMed ID: 4536422
    [No Abstract]   [Full Text] [Related]  

  • 20. Inverse relationship between soluble urokinase receptors and estimated glomerular filtration rate: a role for IL-2?
    Shin JI
    Kidney Int; 2015 May; 87(5):1074. PubMed ID: 25951069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.